z-logo
open-access-imgOpen Access
Evaluation of The Stability and In Vitro Anti-inflammatory Activity of Partially Purified Bromelain Nanoemulsion
Author(s) -
Fransiskus Randy,
Siswati Setiasih,
Mahdi Jufri,
Sri Handayani,
Sumi Hudiyono
Publication year - 2020
Publication title -
iop conference series. materials science and engineering
Language(s) - English
Resource type - Journals
eISSN - 1757-899X
pISSN - 1757-8981
DOI - 10.1088/1757-899x/833/1/012038
Subject(s) - bromelain , ananas , chemistry , chromatography , fractionation , papain , in vitro , dialysis tubing , enzyme , biochemistry , membrane , biology , horticulture
Bromelain is an enzyme belonging to cysteine protease. It is known for topical use as debridement for inflammation treatment. Nanoemulsion of bromelain (NEB) aims to solve this problem and also improve its stability. NEB was made by high emulsification method using homogenizer and sonicator. Nanoemulsion physicochemical stabilities were evaluated. The bromelain as an active compound was isolated from the core of pineapple ( Ananas comosus [L.] Merr) which was purified by ammonium sulphate fractionation and then dialysis followed. Nanoemulsion formula 2 was found to be the most suitable formula for encapsulating bromelain with good physicochemical stability after 30 days of storage. This formula showed clear visual appearance with globule diameter of 37.42 nm with polydispersity index of 0.40. The result showed that the fraction of bromelain obtained from each purification step showed an increase in specific activity. The specific activities of fractionation using 20-50% ammonium sulphate and dialysis were 152.05 and 266.58 U/mg, respectively. The purest bromelain fraction was encapsulated into nanoemulsion formula 2. The bromelain fraction’s anti-inflammatory activity was tested based on HRBC membrane stabilization method. The result showed that bromelain dialysis fraction shows the ability as anti-inflammatory agent with stability percentage of 79.76%.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here